MV

Miquel Vila-Perello

CEO

Splice Bio

Barcelona, Catalonia


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Splice Bio
Industry
biotechnology
Employees
45.0
Seniority
C suite
Annual Revenue
1200000.0
Total Funding
58785555.0
Latest Funding
Series A

Technologies

Outlook Nginx Apache Google Tag Manager WordPress.org Mobile Friendly Google Font API reCAPTCHA

Keywords

genetic therapy protein splicing gene therapy aav vectors stargardt disease abca4 mutations clinical trials inds approval therapeutic modalities eye diseases pharmaceutical research gene delivery systems novel therapeutics clinical development biologic treatment ocular genetics inherited retinal diseases gene mutation orphan drug designation drug development clinical study design protein engineering scientific research biomedical innovations phase 1 trials phase 2 trials biotechnology company biotech innovations retinal degeneration pharmaceutical industry genomic medicine therapy pipeline disease progression studies patient enrollment safety & efficacy studies drug efficacy targeted therapy patient outcomes scientific collaboration clinical endpoints translational medicine biopharmaceuticals therapeutic areas commercial partnerships molecular biology research & development health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans